These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 9536447)
1. Effects of hallucinogens on locomotor and investigatory activity and patterns: influence of 5-HT2A and 5-HT2C receptors. Krebs-Thomson K; Paulus MP; Geyer MA Neuropsychopharmacology; 1998 May; 18(5):339-51. PubMed ID: 9536447 [TBL] [Abstract][Full Text] [Related]
2. LSD and the phenethylamine hallucinogen DOI are potent partial agonists at 5-HT2A receptors on interneurons in rat piriform cortex. Marek GJ; Aghajanian GK J Pharmacol Exp Ther; 1996 Sep; 278(3):1373-82. PubMed ID: 8819525 [TBL] [Abstract][Full Text] [Related]
3. Behavioral tolerance to lysergic acid diethylamide is associated with reduced serotonin-2A receptor signaling in rat cortex. Gresch PJ; Smith RL; Barrett RJ; Sanders-Bush E Neuropsychopharmacology; 2005 Sep; 30(9):1693-702. PubMed ID: 15756304 [TBL] [Abstract][Full Text] [Related]
4. Distinct temporal phases in the behavioral pharmacology of LSD: dopamine D2 receptor-mediated effects in the rat and implications for psychosis. Marona-Lewicka D; Thisted RA; Nichols DE Psychopharmacology (Berl); 2005 Jul; 180(3):427-35. PubMed ID: 15723230 [TBL] [Abstract][Full Text] [Related]
5. 5-HT(2A) and 5-HT(2C) receptors exert opposing effects on locomotor activity in mice. Halberstadt AL; van der Heijden I; Ruderman MA; Risbrough VB; Gingrich JA; Geyer MA; Powell SB Neuropsychopharmacology; 2009 Jul; 34(8):1958-67. PubMed ID: 19322172 [TBL] [Abstract][Full Text] [Related]
6. Cross-tolerance studies of serotonin receptors involved in behavioral effects of LSD in rats. Krebs KM; Geyer MA Psychopharmacology (Berl); 1994 Jan; 113(3-4):429-37. PubMed ID: 7862855 [TBL] [Abstract][Full Text] [Related]
7. Effect of LSD on prepulse inhibition and spontaneous behavior in the rat. A pharmacological analysis and comparison between two rat strains. Ouagazzal A; Grottick AJ; Moreau J; Higgins GA Neuropsychopharmacology; 2001 Oct; 25(4):565-75. PubMed ID: 11557170 [TBL] [Abstract][Full Text] [Related]
8. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats. Kleven MS; Assié MB; Koek W J Pharmacol Exp Ther; 1997 Aug; 282(2):747-59. PubMed ID: 9262338 [TBL] [Abstract][Full Text] [Related]
9. Phospholipase C mediates (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-, but not lysergic acid diethylamide (LSD)-elicited head bobs in rabbit medial prefrontal cortex. Schindler EA; Harvey JA; Aloyo VJ Brain Res; 2013 Jan; 1491():98-108. PubMed ID: 23123701 [TBL] [Abstract][Full Text] [Related]
10. Complex discriminative stimulus properties of (+)lysergic acid diethylamide (LSD) in C57Bl/6J mice. Benneyworth MA; Smith RL; Barrett RJ; Sanders-Bush E Psychopharmacology (Berl); 2005 Jun; 179(4):854-62. PubMed ID: 15645221 [TBL] [Abstract][Full Text] [Related]
11. Serotonergic and dopaminergic distinctions in the behavioral pharmacology of (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) and lysergic acid diethylamide (LSD). Schindler EA; Dave KD; Smolock EM; Aloyo VJ; Harvey JA Pharmacol Biochem Behav; 2012 Mar; 101(1):69-76. PubMed ID: 22197710 [TBL] [Abstract][Full Text] [Related]
12. LSD and DOB: interaction with 5-HT2A receptors to inhibit NMDA receptor-mediated transmission in the rat prefrontal cortex. Arvanov VL; Liang X; Russo A; Wang RY Eur J Neurosci; 1999 Sep; 11(9):3064-72. PubMed ID: 10510170 [TBL] [Abstract][Full Text] [Related]
13. Electrophysiological evidence for a functional interaction between 5-HT1A and 5-HT2A receptors in the rat medial prefrontal cortex: an iontophoretic study. Ashby CR; Edwards E; Wang RY Synapse; 1994 Jul; 17(3):173-81. PubMed ID: 7974200 [TBL] [Abstract][Full Text] [Related]
14. Hallucinogenic 5-HT2AR agonists LSD and DOI enhance dopamine D2R protomer recognition and signaling of D2-5-HT2A heteroreceptor complexes. Borroto-Escuela DO; Romero-Fernandez W; Narvaez M; Oflijan J; Agnati LF; Fuxe K Biochem Biophys Res Commun; 2014 Jan; 443(1):278-84. PubMed ID: 24309097 [TBL] [Abstract][Full Text] [Related]
15. Direct injection of 5-HT2A receptor agonists into the medial prefrontal cortex produces a head-twitch response in rats. Willins DL; Meltzer HY J Pharmacol Exp Ther; 1997 Aug; 282(2):699-706. PubMed ID: 9262333 [TBL] [Abstract][Full Text] [Related]
16. Thieno[3,2-b]- and thieno[2,3-b]pyrrole bioisosteric analogues of the hallucinogen and serotonin agonist N,N-dimethyltryptamine. Blair JB; Marona-Lewicka D; Kanthasamy A; Lucaites VL; Nelson DL; Nichols DE J Med Chem; 1999 Mar; 42(6):1106-11. PubMed ID: 10090793 [TBL] [Abstract][Full Text] [Related]
17. The hallucinogen 1-[2,5-dimethoxy-4-iodophenyl]-2-aminopropane (DOI) increases cortical extracellular glutamate levels in rats. Scruggs JL; Schmidt D; Deutch AY Neurosci Lett; 2003 Aug; 346(3):137-40. PubMed ID: 12853103 [TBL] [Abstract][Full Text] [Related]
18. LSD but not lisuride disrupts prepulse inhibition in rats by activating the 5-HT(2A) receptor. Halberstadt AL; Geyer MA Psychopharmacology (Berl); 2010 Feb; 208(2):179-89. PubMed ID: 19937319 [TBL] [Abstract][Full Text] [Related]
19. Characterisation of human 5-hydroxytryptamine2A and 5-hydroxytryptamine2C receptors expressed in the human neuroblastoma cell line SH-SY5Y: comparative stimulation by hallucinogenic drugs. Newton RA; Phipps SL; Flanigan TP; Newberry NR; Carey JE; Kumar C; McDonald B; Chen C; Elliott JM J Neurochem; 1996 Dec; 67(6):2521-31. PubMed ID: 8931486 [TBL] [Abstract][Full Text] [Related]
20. Blockade of the discriminative stimulus effects of DOI by MDL 100,907 and the 'atypical' antipsychotics, clozapine and risperidone. Schreiber R; Brocco M; Millan MJ Eur J Pharmacol; 1994 Oct; 264(1):99-102. PubMed ID: 7530204 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]